Press release
Shaping the Infectious Disease Therapeutics Market in 2025: Corporate Initiatives In Infectious Disease Therapeutics Advancing Treatment, Resisting Resistance, and Promoting Global Health Equity
Infectious Disease Therapeutics Market Size
The market for therapeutics in infectious diseases has seen significant expansion in past years. From $141.08 billion in 2024, the industry is projected to reach $151.04 billion in 2025, marking a compound annual growth rate (CAGR) of 7.1%. Factors accounting for this historical growth pattern include a surge in infectious disease cases, a rise in viral disease occurrences, increased consciousness about diagnosis, swelling demand for rapid and efficient diagnostic testing, heightened preference for affordable generic drugs, escalating incidences of infectious diseases, and a heightened emphasis on antimicrobial stewardship.
A surge of growth is anticipated in the infectious disease therapeutics market size in the coming years, predicted to reach $196.5 billion by 2029 at a compound annual growth rate (CAGR) of 6.8%. Factors contributing to this progression during the projection period includes heightened investments, broadened clinical trial investigations, a rising tally of clinical trials, a sharpening concentration on preventing infectious diseases, increased knowledge about the importance of early diagnosis, as well as growing understanding and funding. The anticipated period will likely see collaboration, product endorsement, investment, and exploration and advancements in therapeutics as significant trends.
What Are the Forces Behind the Rapid Growth of the Infectious Disease Therapeutics Market?
The increase in infectious diseases is anticipated to fuel the expansion of the infectious disease therapeutics market. Pathogenic microorganisms, including bacteria, viruses, fungi, parasites, and prions, cause these diseases. Numerous critical factors, like climate and environmental changes, antimicrobial resistance, compromised immune systems, and greater interaction with animals, have led to the surge in infectious diseases. Therapeutics for infectious diseases are crucial for disease treatment, lowering disease-related deaths and illnesses, and managing the transmission of communicable diseases within and among populations. For example, the Centers for Disease Control and Prevention, a US government agency, reported in November 2023 that the US had 8,331 tuberculosis (TB) cases in 2022, signifying an incidence rate of 2.5 per 100,000 people. These figures indicated a 5.9% increase in the number of incidences and a 5.5% rise in the incidence rate compared to 2021. Thus, the escalating prevalence of infectious diseases is driving the growth of the infectious disease therapeutics market.
Get Your Free Sample Now - Explore Exclusive Market Insights:
https://www.thebusinessresearchcompany.com/sample.aspx?id=15594&type=smp
Who Are the Dominant Companies Influencing Infectious Disease Therapeutics Market Trends?
Major companies operating in the infectious disease therapeutics market are Pfizer Inc., Roche Diagnostics Corporation, F. Hoffmann-La Roche AG, Merck & Co. Inc., Sanofi SA, Thermo Fisher Scientific, AstraZeneca, Abbott Laboratories, Novartis International AG, Danaher Corporation, GlaxoSmithKline plc, Gilead Sciences Inc., Janssen Pharmaceutical, Siemens Healthineers, Moderna Inc., Becton, Dickinson, and Company, Regeneron Pharmaceuticals Inc., Boehringer Ingelheim GmbH, BioMérieux SA, Sysmex Corporation, Bio-Rad Laboratories, Qiagen N.V., Ortho Clinical Diagnostics, BioCryst Pharmaceuticals Inc.
How Is the Infectious Disease Therapeutics Market Evolving?
Leading entities in the infectious disease therapeutics market are directing their funds towards the development of increasingly successful treatments for infectious diseases, with the aim of combating antimicrobial resistance, broadening their range of products, and tackling rising infectious threats. The objective behind these financial commitments is to enhance patient recovery, respond to unfulfilled medical necessities, and support worldwide public health campaigns to monitor and manage infectious diseases. For instance, in June 2022, GSK, a healthcare organization located in the UK, allotted £1 billion ($1.09 billion) to proactively manage infectious diseases in countries with lower income levels. Through this program, they aim to reinforce research and developmental efforts to fight diseases that take a heavier toll on these regions. The pronounced gap in health research funding and resources between wealthier nations and low- to middle-income nations highlights the pressing need for such calculated investments to promote fair health improvement across populations.
What Are the Different Segmentations in the Infectious Disease Therapeutics Market?
The infectious disease therapeutics market covered in this report is segmented -
1) By Type: Drugs, Vaccines
2) By Disease: Tuberculosis, HIV/AIDS, Influenza, Hepatitis, Other Diseases
3) By End-User: Hospitals And Clinics, Retail Pharmacies, Research Organizations, Other End Users
Subsegments:
1) By Drugs - Antibiotics, Antivirals, Antifungals, Antiparasitics, Other Therapeutic Drugs (Monoclonal Antibodies, Immunomodulators)
2) By Vaccines - Inactivated Vaccines, Live Attenuated Vaccines, Subunit Vaccines, Mrna Vaccines, Dna Vaccines, Toxoid Vaccines
Pre-Book Your Report Now For A Swift Delivery:
https://www.thebusinessresearchcompany.com/report/infectious-disease-therapeutics-global-market-report
Which Region Is at the Forefront of the Infectious Disease Therapeutics Market?
North America was the largest region in the infectious disease therapeutics market in 2023. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the infectious disease therapeutics market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.
What Is Covered In The Infectious Disease Therapeutics Global Market Report?
- Market Size Analysis: Analyze the Infectious Disease Therapeutics Market size by key regions, countries, product types, and applications.
- Market Segmentation Analysis: Identify various subsegments within the Infectious Disease Therapeutics Market for effective categorization.
- Key Player Focus: Focus on key players to define their market value, share, and competitive landscape.
- Growth Trends Analysis: Examine individual growth trends and prospects in the Market.
- Market Contribution: Evaluate contributions of different segments to the overall Infectious Disease Therapeutics Market growth.
- Growth Drivers: Detail key factors influencing market growth, including opportunities and drivers.
- Industry Challenges: Analyze challenges and risks affecting the Infectious Disease Therapeutics Market.
- Competitive Developments: Analyze competitive developments, such as expansions, agreements, and new product launches in the market.
Unlock Exclusive Market Insights - Purchase Your Research Report Now!
https://www.thebusinessresearchcompany.com/purchaseoptions.aspx?id=15594
Connect with us on:
LinkedIn: https://in.linkedin.com/company/the-business-research-company,
Twitter: https://twitter.com/tbrc_info,
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ.
Contact Us
Europe: +44 207 1930 708,
Asia: +91 88972 63534,
Americas: +1 315 623 0293 or
Email: mailto:info@tbrc.info
Learn More About The Business Research Company
With over 15,000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Our flagship product, the Global Market Model delivers comprehensive and updated forecasts to support informed decision-making.
This release was published on openPR.
Permanent link to this press release:
Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.
You can edit or delete your press release Shaping the Infectious Disease Therapeutics Market in 2025: Corporate Initiatives In Infectious Disease Therapeutics Advancing Treatment, Resisting Resistance, and Promoting Global Health Equity here
News-ID: 3861385 • Views: …
More Releases from The Business Research Company
Segment Evaluation and Major Growth Areas in the Personalized Testing and Supple …
The personalized testing and supplements sector is gaining remarkable traction, driven by advancements in technology and a rising consumer focus on tailored health solutions. As more individuals seek customized wellness options, this market is set to experience substantial expansion in the coming years. Here's an in-depth look at its current valuation, key players, significant trends, and the main market segments shaping its future.
Market Valuation and Expansion Forecast for Personalized Testing…
Top Players and Market Competition in the Skin Microbiome Industry
The skin microbiome market is emerging as a significant area of interest due to growing awareness about the critical role of skin health and innovative skincare technologies. As research advances and consumer preferences shift towards more natural and science-backed products, this market is set to undergo substantial growth. Let's explore the current market size, key players, driving factors, and upcoming trends shaping the skin microbiome industry.
Projected Expansion in the Skin…
Key Strategic Developments and Emerging Changes Shaping the Upadacitinib Market …
The upadacitinib market is poised for significant expansion over the coming years, driven by advances in treatment options and increasing awareness of autoimmune diseases. This report delves into the market's current size, key drivers, major players, and the emerging trends shaping its future trajectory.
Steady Growth Expected in Upadacitinib Market Size Through 2029
The market for upadacitinib is projected to reach $2.54 billion by 2029, growing at a robust compound annual…
Analysis of Key Market Segments Driving the Alzheimer's Disease Diagnostic Marke …
The Alzheimer's disease diagnostic sector is rapidly evolving as advancements in technology and healthcare infrastructure open new possibilities for early detection and personalized treatment. With rising awareness and innovative approaches, this market is poised for significant growth in the coming years. Let's explore the current market size, key drivers, leading companies, and emerging trends that are shaping this critical healthcare field.
Projected Market Size and Growth Trends in Alzheimer's Disease Diagnostics…
More Releases for Disease
Protheragen Announces Disease Model Development Services to Enhance Rare Disease …
Protheragen announced the release of its disease model development services provided to enhance rare disease research. With an increasing focus on rare diseases and the need for tailored research models, Protheragen is dedicated to providing cutting-edge solutions to support this important area of medical research.
Rare diseases, which affect a small percentage of the population, pose unique challenges for researchers due to their limited understanding and lack of available treatment options.…
Biopharmaceutical Fermentation Market 2022 | Growing Morbidity of Genetic Diseas …
According to Precision Business Insights (PBI), the latest report, the biopharmaceutical fermentation market is expected to be valued at USD 10,302.1 million in 2022, growing at a 4.7% CAGR from 2022 to 2028. The growing prevalence of chronic illness, cancer, cardiac diseases, infectious diseases, antibiotic resistance, autoimmune diseases, etc., globally causes the leaning toward biopharmaceutical products, which show promising results in the research studies. Moreover, new findings by the…
Global Inflammatory Bowel Disease (IBD) Market Key Players Analysis, Disease Ind …
Global Inflammatory Bowel Disease (IBD) Market, valued at USD 210.5 Billion in the year 2020 has been driven by factors such as the increasing prevalence of Ulcerative Colitis and Crohn’s Disease, advances in medical technology, government support for inflammatory bowel disease treatment research, and the ubiquity of anxiety and depression. Moreover, factors such as the irregular food habits, unhealthy lifestyle of people, increased level of pollution and increase in alcohol…
Moyamoya Disease Market - A Scientometric Assessment of Disease During 2018-23
Market Highlight:
Moyamoya disease (MMD) is a chronic, cerebrovascular disease characterized by progressive stenosis in the internal carotid artery and an abnormal vascular network at the base of the brain. The stroke is one of the significant symptoms of moyamoya disease, which further leads to paralysis of the face, arms, and legs, loss of speech, and temporary loss of neurologic function of body parts, visual disturbances, headaches, developmental delay, and…
Refsum Disease Industry An Overview of A New Disease - 2018
"Refsum Disease" is a genetic disorder which is inherited as an autosomal recessive trait. The condition is characterized by progressive loss of vision (retinitis pigmentosa), failure of muscle coordination (ataxia), degenerative nerve disease (peripheral neuropathy), and dry, rough, scaly skin (ichthyosis). The accumulation of fatty acid (phytanic acid) in blood plasma and tissues is the main cause of refsum disease. This occurs due to malfunction of the enzyme producing gene…
Chagas Disease (Infectious Disease) Pipeline Forecast Report, H1, 2017 [MRH]
Market Research Hub's Pharmaceutical and Healthcare latest pipeline guide Chagas Disease - Pipeline Review, H1 2017, provides comprehensive information on the therapeutics under development for Chagas Disease Market (Infectious Disease), complete with analysis by stage of development, drug target, mechanism of action (MoA), route of administration (RoA) and molecule type. The guide covers the descriptive pharmacological action of the therapeutics, its complete research and development history and latest news and…
